ANI Pharma Inc
(ANIP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANIP | AZN | AMGN | GILD | BMY |
| Company | ANI Pharma Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 79.90 | 200.08 | 365.14 | 148.90 | 60.60 |
| High | 79.94 | 200.89 | 365.14 | 154.50 | 60.65 |
| Low | 78.70 | 199.19 | 361.00 | 147.38 | 59.87 |
| Latest | 78.01 | 200.54 | 364.08 | 152.75 | 60.11 |
| Change | -1.90 | +7.14 | -0.57 | +5.52 | -0.75 |
| % Change | -2.38% | +3.69% | -0.16% | +3.75% | -1.23% |
| Volume | 7,598 | 362,397 | 130,503 | 1,116,134 | 528,695 |
| 20-Day Average Volume | 429,045 | 4,505,960 | 3,059,859 | 8,109,383 | 13,105,266 |
| Previous Close | 79.91 | 193.40 | 364.65 | 147.23 | 60.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 82.21 | 187.92 | 349.50 | 138.90 | 56.71 |
| 20-Day Raw Stochastic | 16.28% | 97.95% | 66.80% | 99.14% | 77.66% |
| 20-Day Relative Strength | 44.68 | 62.37 | 59.62 | 72.19 | 65.35 |
| Weighted Alpha | +18.58 | +43.75 | +31.12 | +58.63 | +22.67 |
| Today's Opinion | 16% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 16% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 32% Buy | 100% Buy | 64% Buy | 56% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.10% since 02/04/26 | +6.73% since 02/04/26 | -0.58% since 02/04/26 | +5.46% since 02/04/26 | +4.39% since 02/04/26 |
| Low | 78.38 on 02/09/26 | 186.58 on 02/05/26 | 361.00 on 02/11/26 | 145.87 on 02/05/26 | 58.00 on 02/05/26 |
| High | 83.80 on 02/05/26 | 200.53 on 02/11/26 | 385.12 on 02/06/26 | 154.50 on 02/11/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | +4.30% since 01/09/26 | +5.69% since 01/09/26 | +11.64% since 01/09/26 | +27.34% since 01/09/26 | +7.68% since 01/09/26 |
| Low | 78.10 on 01/28/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 87.07 on 01/16/26 | 200.53 on 02/11/26 | 385.12 on 02/06/26 | 154.50 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | -10.14% since 11/11/25 | +12.29% since 11/11/25 | +7.57% since 11/11/25 | +25.82% since 11/11/25 | +23.46% since 11/11/25 |
| Low | 75.10 on 01/09/26 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 89.57 on 11/12/25 | 200.53 on 02/11/26 | 385.12 on 02/06/26 | 154.50 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | -6.27% since 08/11/25 | +35.05% since 08/11/25 | +27.70% since 08/11/25 | +28.01% since 08/11/25 | +30.96% since 08/11/25 |
| Low | 75.10 on 01/09/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 99.50 on 09/10/25 | 200.53 on 02/11/26 | 385.12 on 02/06/26 | 154.50 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,795,497 | 299,945,568 | 196,357,104 | 182,665,312 | 123,895,928 |
| Shares Outstanding, K | 22,469 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 614,380,000 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -18,520,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 227,810,000 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 26,620,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 0.50 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.04 on 11/07/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/27/26 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 14.00 | 20.57 | 17.20 | 18.52 | 9.88 |